413 search results for “anticancer drug steen” in the Staff website
-
PhD sessions Leiden University Libraries
Research
-
ICT-contact persons
For each university unit, the ICT Shared Service Centre (ISSC) has an appointed ICT contact person responsible for applying for ICT facilities for research, teaching and operational management.
-
These were Leiden University’s interdisciplinary milestones of 2024
Connecting scientific fields, enhancing research and teaching, and providing innovative solutions to complex social issues: that is the idea behind interdisciplinary research. What did the university achieve in 2024? A small sample.
-
Veni grant for ten Leiden researchers
Ten Leiden researchers have been awarded a Veni grant by the Dutch Research Council (NWO). The grant, of up to 280,000 euros, will enable them to elaborate their ideas over a period of three years.
-
“You look well,” said the oncologist, but she didn't feel that way at all
Leiden psychologists Janine Westendorp and Liesbeth van Vliet have investigated types of communication that seriously ill patients may experience as harmful. The results of this research were published in the American journal Cancer. And the results have now also been published as a poster for education…
-
Regilme wins a 2022 Human Rights Publication Accolade from American Sociological Association
Salvador Santino Regilme received Honorable Mention for the 2022 Best Scholarly Article Award from the Sociology of Human Rights Section of the American Sociological Association (ASA). He won for his paper “Visions of Peace Amidst a Human Rights Crisis: War on Drugs in Colombia and the Philippines,”…
-
‘Pharmacogenetics will become part of patient care’
Does medicine make patients feel better or worse? We are getting better at predicting this from people’s DNA profiles, says Professor Jesse Swen. ‘It never fails to fascinate me how one DNA base pair can have such a huge effect on treatment with medication and the outcome.’
-
‘Exposure therapy’ for bachelor students: preparing for the reality of scientific research
Already during their bachelor’s programme, students in Pharmaceutical Sciences are presented with challenging projects. One of these is the Bachelor Research Assignment (BOO in Dutch), which is often their first real experience with scientific research. This means a lot of responsibility and failures,…
-
Chemotherapy without side effects? It’s possible, with light
Nausea, neurologic pain and hair loss: some of the severe side effects of chemotherapy. Not necessary, biochemist Liyan Zhang showed. Together with Leiden biologists and others, she achieved great results with a drug that is only active in combination with light. Zhang will defend her PhD on 4 July.
-
Dutch Medicines Days
The FIGON Dutch Medicines Days is the conference where partners from industry, scientific and professional associations, universities, and government present their findings in the field of innovative drug research & development, share new scientific insights and results, exchange experiences and information,…
-
Sebastian Pomplun joins Oncode Institute to accelerate breakthroughs in cancer research
Sebastian Pomplun manages to reach proteins with drugs even where this was thought impossible. That is why he and his research group have been allowed to join Oncode Institute. With nine others, he had been selected from 72 applicants to contribute to Oncode Institute's mission: to accelerate breakthroughs…
-
Johan Kuiper
Science
j.kuiper@lacdr.leidenuniv.nl | 071 5274378
-
Lucie Delfos
Science
l.delfos@lacdr.leidenuniv.nl | 071 5272727
-
Majlen Dilweg
Science
m.a.dilweg@lacdr.leidenuniv.nl | 071 5272727
-
Ischa Bremer
Science
i.l.bremer@lacdr.leidenuniv.nl | 071 5272727
-
Congrou Zhang
Science
c.zhang@lacdr.leidenuniv.nl | 071 5272727
-
Master student Nicole ter Laak wins third “Dr. Saal van Zwanenberg research price”
Nicole ter Laak (Master student Biopharmaceutical sciences) has won the third price of the “Dr Saal van Zwanenberg research price”. The award ceremony is on 14 November.
-
Selective cannabinoid CB2 receptor activation in Nature Communications
This March, Jara Bouma, Cas van der Horst and Laura Heitman from the Division of Drug Discovery and Safety and Laura de Paus, Richard van den Berg, Anthe Janssen and Mario van der Stelt from the LIC joined forces to determine how some drugs can specifically target the cannabinoid CB2 receptor (CB2R)…
-
Powerful new Leiden 'super antibiotic' may overcome resistance
The prestigious journal Science Translational Medicine has published a study by researchers from the Institute of Biology Leiden (IBL) on a potent new antibiotic that can overcome resistance. ‘The idea was to tweak the original antibiotic and create a next-generation drug’, says Nathaniel Martin, professor…
-
700,000 euros for the fight against aggressive breast cancer
To inhibit proteins that contribute to the growth of aggressive cancer cells, that’s the plan of Professor Bob van de Water and his team. They will receive over 700,000 euros from the KWF Dutch Cancer Society for their research. Researcher Maaike Vreeswijk and pathologist Danielle Cohen are affiliated…
-
Jessica den Oudsten wins the eighth Uitgeverij Verloren/ Johan de Witt thesis award
Jessica den Oudsten won this year’s Uitgeverij Verloren/Johan de Witt thesis award for history with her master’s thesis, entitled "The descendants of Norwegian and Danish Immigrants". The prize was awarded for the eighth time in collaboration with Elsevier Weekblad. The incentive award went to Amber…
-
Zware metalen hebben slechte reputatie, maar genezen ook kanker
Veel mensen denken dat zware metalen giftig zijn en mens en natuur altijd schade aanbrengen. Dat beeld moet genuanceerd worden, vindt hoogleraar Sylvestre Bonnet.
-
One million euros grant for smart antibiotic combinations – tackling resistant infections and antimicrobial resistance
Optimised antibiotic combinations can combat bacteria more effectively while also slowing the development of resistance. Scientists from five European countries are joining forces to identify such combinations and provide tools for others to do the same. The project is led by Professor Coen van Hasselt…
-
Referral options
If you’re unsure where to refer students to for well-being support, this page should help. It provides an overview of the support available at Leiden University.
-
Pharma-NL application submitted to National Growth Fund
The Ministry of Health, Welfare and Sport (VWS) submitted Pharma-NL to the R&D program of the National Growth Fund, a 20 billion euro program of the Dutch government that intends to create long-term economic growth in The Netherlands.
-
Funding for four Leiden studies in the fight against arthritis
Four researchers from Leiden University will receive funding from arthritis foundation ReumaNederland over the next five years. This should facilitate long-term research into arthritis.
-
Leiden researchers join forces against tuberculosis
About one and a half million people worldwide die each year from tuberculosis. For thirty years, therapy with antibiotics has been the same, while it takes far too long and can lead to resistant pathogens. Leiden researchers from four institutes are now joining forces to develop more effective and efficient…
-
Discover the Oncode Accelerator research funds for cancer therapies
Research
-
Fighting gliobastoma brain tumours with two grants
Few researchers see potential in research on glioblastoma, an incurable brain tumour. Alexander Kros brought together colleagues who are up to the challenge. European research funder ERC recently made 10.6 million euros available, a year earlier NWO provided 3 million euros. ‘In six years, we certainly…
-
No higher risk of miscarriage after COVID-19
LUMC research has shown that women who previously had a miscarriage due to COVID-19 are not at increased risk of having another miscarriage or a stillbirth. Nor are preventive drugs needed during the pregnancy.
-
Salvador Santino Regilme awarded fellowship at NIAS
Salvador Santino Regilme has been selected for a fellowship at the Netherlands Institute for Advanced Study (NIAS) in Amsterdam. From September 2022, he will spend 5 months at NIAS working on his research project titled 'The Normative Order of the Global War on Drugs'.
-
Professor and Knight: Joke Bouwstra Receives Royal Honor
A memorable farewell symposium and a royal distinction: Professor Joke Bouwstra could not have completed her career at Leiden with more pleasure. On Friday, 14 June, she received a Royal Honor from Leiden Mayor Peter van der Velden, who appointed Bouwstra as a Knight in the Order of the Dutch Lion for…
-
Joke Bouwstra is the first woman to receive the Dr Saal van Zwanenberg Honorary Prize: 'Wonderful to be in a line of distinguished scientists'
Emeritus professor Joke Bouwstra (LACDR) will receive this year's Dr Saal van Zwanenberg Ereprijs: a tribute to her years of fundamental research on the skin and the transport of drugs through the skin. This is the first time the prize has gone to a woman.
-
LACDR EMA Lunchtalk
On Friday the 29th of October, LACDR presented highlights of its research and teaching program during an online Lunchtime Talk session at the European Medicines Agency (EMA).
-
Willem Jespers wins the international Rottendorf Foundation Award for Pharmacy and Pharmacology 2023
Willem Jespers was awarded the international prize, worth €10,000, for pharmacy and pharmacology from the Rottendorf foundation on October 13th 2023 at the University of Münster. He was recognized for his research in the field of computer-aided drug development and the prediction of drug toxicities.…
-
Successful symposium on Circuit Topology
On the 8th of December 2021, Leiden Academic Centre for Drug Research (LACDR) organized “Circuit Topology 2021”, the first international symposium on circuit topology. The focus was on the mathematical notion of Circuit Topology, and its applications to physics, chemistry and biomedicine.
-
Versatile antiviral proteins discovered with supercomputer
A single tiny molecule that can destroy flu, corona, HIV and Zika viruses? Yes, it really does exist. Biophysicist Niek van Hilten, who will receive his doctorate on 14 September, contributed to this discovery.
-
Better treatment of skin diseases thanks to NWA grant of 11.7 million euros
Patients with skin diseases such as eczema and psoriasis, sometimes spend a lifetime searching for the right medication. To help these patients faster and better, scientists across the country are joining forces. The Next Generation ImmunoDermatology (NGID) project, with LACDR professor Robert Rissmann…
-
3 October University: ‘Artificial intelligence is like young people and sex’
‘Everyone’s talking about it, everyone thinks everyone else is doing it, but the reality is disappointing,’ says biochemist Gerard van Westen in his 3 October University lecture in the Van der Werfpark. In the full marquee, he gets a laugh with this suggestion that artificial intelligence is comparable…
-
Anne van Rongen
Science
a.van.rongen@lacdr.leidenuniv.nl | 071 5272727
-
Awarded research project Next Generation ImmunoDermatology: Towards Biomarker-driven Dermatology practice in the Netherlands
The Dutch Research Council (NWO) has, within the framework of Research along Routes by Consortia (NWA-ORC), awarded the research project Next Generation Immuno-Dermatology (NGID) with a prestigious grant of 11.7 MEuro. NGID is a nationwide, large-scale project to unravel novel biomarkers for six different…
-
Developing new therapies to fight muscle disease
Biophysicist Alireza Mashaghi and his collaborators are taking up the fight against muscular dystrophy: genetic disorders that cause muscle weakness. They want to inhibit the clumping of proteins that results in toxic aggregates. For this, the team receives 550,000 euros from Health Holland. The team…
-
Four NWO Open Competition grants for Leiden researchers
Four researchers from Leiden University have been awarded NWO Open Competition grants in the Science domain. This is for research into subjects such as immune cells in tumours, antibiotic resistance and magnetic semiconductors.
-
Recent PhD defenses
Here we highlight the achievements of our latest PhD graduates, each of whom has made significant contributions to the advancement of the field of (bio)pharmaceutical sciences.
-
ERC-grant for Sebastian Pomplun to cure disease by controlling gene expression with synthetic transcription factors
Sebastian Pomplun receives an ERC starting grant of 1.85 million Euros in five years. He wants to develop synthetic transcription factors that can enter cells and activate or deactivate specific genes. For example to disrupt cancer-related processes or to trigger the production of an important missing…
-
Wanda van der Stel - ALTEX Prize Winner 2022
The members of the Board of ALTEX Edition, the ALTEX Editorial Board and ALTEX Editorial Office elect the winner of the annual award out of all main articles published in the previous year; articles including members of the Board of ALTEX Edition or ALTEX Editorial Office as first authors are excluded.…
-
Podcast: A changing view on psychedelics
We talk with Michiel van Elk, about his research into mapping what effects psychedelics have on the human brain and what this means for the possible clinical application of these drugs. The cognitive psychologist shares his findings with a sober view, bringing critics and fanatics closer together for…
-
Leiden University bids farewell to Mayor Lenferink
This week, Leiden University bade farewell to Henri Lenferink, who is retiring after 20 years as mayor of Leiden.
-
Graduation ceremony of the Cyber Security master: A digital party
With a trip through the Netherlands, the preparations for the graduation of the Master Cyber Security had already started weeks ago. The apotheosis took place on Thursday, the 11th of February. A report of a digital graduation ceremony.
-
Podcast series introduces you to the BSc Security Studies
With this podcast series 'Introduction to Security Studies', you will get to know more about the bachelor's programme Security Studies at Leiden University in The Hague and life as a student in The Hague.